Ozempic®—a once-weekly injectable formulation of semaglutide—is approved in India for adults with type 2 diabetes as the first line treatment, adjunct to diet and exercise. While effectively reducing blood sugar, Ozempic® is clinically proven to provide compelling weight-loss benefits in people with diabetes In addition to powerful HbA1C control and …
Read More »
Breaking News
- Allen Green Announces Updated Holdings in Akwaaba Mining Ltd. and Filing of Early Warning Report
- TMX Group Equity Financing Statistics – February 2026
- Wendt Partners Recognized as a Top HubSpot Partner for Manufacturing Companies
- The Andrew Hillman Grant for Biotech Launches Innovative Grant for Biotech Undergraduate Students to Shape the Future of Healthcare and Science
- Dr. Ian Weisberg Grant Announces Launch of Prestigious Scholarship Program for Undergraduate Healthcare Students
- Dr. Kofi Sarfo Launches Dr. Kofi Sarfo Scholarship for Future Doctors to Advance Medical Education and Service Leadership
- Dr. Scott Kamelle Scholarship Program Announces 2026 Launch to Support Aspiring Medical Professionals
- Rose Sarfo Scholarship for Healthcare Students Announces National Opportunity to Advance Service-Driven Healthcare Education
- SATO Technologies Corp. Announces Private Placement for Gross Proceeds of Up To C$1.3 Million
- Lycos Energy Inc. Announces Strategic Business Combination with Mahikan Oil Corporation and $30.0 Million Equity Offering
Matribhumi Samachar
Address : 125 - Rajiv Nagar, Vinayakpur, Kanpur - 208025
Mo. No.: 8303063085
Email: [email protected]
Managed By Y2KSOLUTION
Copyright © Matribhumi Samachar